Filtered By:
Vaccination: Hepatitis Vaccine
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 557 results found since Jan 2013.
One Dose Of Coronavirus Vaccine Likely Won ’ t Be Enough; ‘ We ’ re Looking At Double Shots ’
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4683970","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 31, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Coronavirus Coronavirus Vaccine Source Type: news
TWiV 670: Coronavirus vaccine preparedness with Kizzmekia Corbett
Kizzmekia Corbett joins TWiV to review her career and her work on respiratory syncytial virus, influenza virus, and coronaviruses and coronavirus vaccines, including her role in development and testing of a spike-encoding mRNA vaccine, and then we review the Nobel Prize for discovery of hepatitis C virus. Click arrow to playDownload TWiV 670 (76 MB .mp3, […]
Source: virology blog - October 8, 2020 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology coronavirus COVID-19 influenza virus mRNA-1273 pandemic prefusion conformation respiratory syncytial virus SARS-CoV-2 spike vaccine viral viruses Source Type: blogs
Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies
CONCLUSION: The influenza vaccine does not increase the risk of a coronavirus infection. Instead, the influenza vaccine may reduce the rate of coronavirus infections by inducing cross-reactive anti-coronavirus IgG antibodies.PMID:34756613 | PMC:PMC8520850 | DOI:10.1016/j.vaccine.2021.10.021
Source: Vaccine - November 10, 2021 Category: Allergy & Immunology Authors: Andrew T Chen Hannah D Stacey Art Marzok Pardeep Singh Jann Ang Matthew S Miller Mark Loeb Source Type: research
Viruses, Vol. 12, Pages 880: Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2
ahabir
The fatal acute respiratory coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since COVID-19 was declared a pandemic by the World Health Organization in March 2020, infection and mortality rates have been rising steadily worldwide. The lack of a vaccine, as well as preventive and therapeutic strategies, emphasize the need to develop new strategies to mitigate SARS-CoV-2 transmission and pathogenesis. Since mouse hepatitis virus (MHV), severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2 share a common genus, lessons learnt from MHV ...
Source: Viruses - August 11, 2020 Category: Virology Authors: Robert W. K örner Mohamed Majjouti Miguel A. Alejandre Alcazar Esther Mahabir Tags: Review Source Type: research
Viruses, Vol. 14, Pages 1573: Kathryn V. Holmes: A Career of Contributions to the Coronavirus Field
This article provides a review of her contributions to the coronavirus field and her exemplary mentoring.
Source: Viruses - July 20, 2022 Category: Virology Authors: Aurelio Bonavia Samuel R. Dominguez Gabriela Dveksler Sara Gagneten Megan Howard Scott Jeffers Zhaohui Qian Mary Kathryn Smith Larissa B. Thackray Dina B. Tresnan David E. Wentworth David R. Wessner Richard K. Williams Tanya A. Miura Tags: Review Source Type: research
Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Authors: Di Pierro F, Bertuccioli A, Cavecchia I
Abstract
The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans ...
Source: Minerva Gastroenterologica e Dietologica - March 14, 2020 Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
Plagues and People – The Coronavirus in a Historical Perspective
By Jan LundiusSTOCKHOLM / ROME, Mar 19 2020 (IPS) The human factor is intimately involved in the origin, spread, and mitigation of the Coronavirus and we cannot afford to ignore that our future existence depends on compassion and cooperation. Response matters!
Some quarantined Italians might recall Giovanni Boccaccio´s The Decameron from 1353 in which people escaping the plague are secluded in a villa where they tell stories to each other. Boccaccio introduced his collection of short stories with an eyewitness account of horrifying human suffering in Florence, which in 1348 was struck by a ”pestilence” that every day...
Source: IPS Inter Press Service - Health - March 19, 2020 Category: International Medicine & Public Health Authors: Jan Lundius Tags: Global Headlines Health Humanitarian Emergencies TerraViva United Nations Women's Health Source Type: news
In silico analysis highlighting the prevalence of BCL2L1 gene and its correlation to miRNA in human coronavirus (HCoV) genetic makeup
Infect Genet Evol. 2022 Feb 28:105260. doi: 10.1016/j.meegid.2022.105260. Online ahead of print.ABSTRACTThe ongoing pandemic that resulted from coronavirus disease (COVID-19), which is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), had been spiraling out of control with no known antiviral drugs or vaccines. Due to the extremely serious nature of the disease, it has claimed many lives, with a mortality rate of 3.4% declared by the World Health Organization (WHO) on March 3, 2020. The aim of this study is to gain an understanding of the regulatory nature of the proteins involved in COVID-19 and to ex...
Source: Infection, Genetics and Evolution - March 3, 2022 Category: Genetics & Stem Cells Authors: Agnik Haldar Keerti K Yadav Suchitra Singh Piyush K Yadav Ajay K Singh Source Type: research
Effect of an inactivated coronavirus disease 2019 vaccine, CoronaVac, on blood coagulation and glucose: a randomized, controlled, open-label phase IV clinical trial
ConclusionCoronaVac showed a good safety profile and could induce a humoral response against the prototype and VOCs of SARS-CoV-2 in adults 18 years or older, with no abnormal effects on laboratory parameters of blood glucose and coagulation function.
Source: Frontiers in Immunology - May 31, 2023 Category: Allergy & Immunology Source Type: research
Don ’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That ’s not wise, health experts say.
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Paula Span Tags: your-feed-science Whooping Cough Shingles (Disease) Diphtheria Coronavirus (2019-nCoV) Influenza Elderly Epidemics Drugs (Pharmaceuticals) Pneumonia your-feed-healthcare Vaccination and Immunization Hepatitis Tetanus Minorities Source Type: news
Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?”
we read with great interest the article: “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?” by Bril F. et al. recently published in J Hepatol1. In our opinion, several considerations arise leading to stress further the possibility that the described association is indeed coincide ntal, as also acknowledged by the authors.
Source: Journal of Hepatology - May 5, 2021 Category: Gastroenterology Authors: Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Stefano Brillanti Tags: Letter to the Editor Source Type: research
Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?”
We read with interest the recent letter published by Bril et al. titled “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?” recently published in J Hepatol1. The authors describe a possible case of COVID-19 vaccine-associated autoimmune hepatitis (AIH) in a 35-year-old woman 3 months post-partum, who presented with pruritis and jaundice 13 days after receiving a BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine, which may be the first report of COVID-19 vaccine-associated liver injury.
Source: Journal of Hepatology - June 22, 2021 Category: Gastroenterology Authors: Daniel Clayton-Chubb, Daniel Schneider, Elliot Freeman, William Kemp, Stuart K. Roberts Tags: Letter to the Editor Source Type: research
Autoimmune Hepatitis Developing After Coronavirus Disease 2019 (COVID-19) Vaccine: One or Even Several Swallows Do Not Make a Summer
I read with interest the comments to our letter by Londo ño et al (1), Clayton-Chubb et al (2), Tan et al (3), McShane et al (4), and Lodato et al (5), and I appreciate their contribution. All these authors presented similar cases of autoimmune hepatitis (AIH) that developed after coronavirus disease 2019 (COVID-19) vaccine, with the exception of Lodato et al (5), who actually described a case of acute liver injury with some features of autoimmunity.
Source: Journal of Hepatology - August 9, 2021 Category: Gastroenterology Authors: Bril Fernando Tags: Letter to the Editor Source Type: research
